Your session is about to expire
← Back to Search
Elotuzumab for Multiple Myeloma
Study Summary
This trial is testing a new combination of drugs to treat multiple myeloma.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 3 trial • 170 Patients • NCT02726581Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the current size of this medical experiment?
"At the moment, this clinical trial is not recruiting. It was first posted on May 7th 2015 and last updated on December 17 2021. If you're searching for alternatives studies, there are 807 trials currently enrolling patients with multiple myeloma as well as 738 prospective Elotuzumab studies seeking participants."
How prevalent is this medical investigation across the state?
"Patients are being recruited at the moment from 7 sites, with Boston, Hackensack and Saint Louis among them. It is prudent to select a site nearby in order to limit your required travel if accepted into this trial."
Are there other experiments that have utilized Elotuzumab?
"First documented in 2002, elotuzumab has been the subject of 1614 clinical trials and currently 738 studies remain active. Many of these investigations are based out of Boston, Massachusetts."
What clinical indications does Elotuzumab typically address?
"Elotuzumab is a valuable treatment for ailments such as ophthalmia, sympathetic and branch retinal vein occlusion. Moreover, it can be helpful to patients who have had at least two rounds of systemic chemotherapy regimens or are suffering from macular edema."
Has Elotuzumab been given the greenlight by the FDA?
"There is limited data available to evaluate elotuzumab's safety, so it receives an estimated score of 2."
Are there any opportunities to join this clinical trial at present?
"At present, this trial is not in the process of enrolling patients. It was first put up on May 7th 2015 and updated December 17th 2021; however, if one wishes to investigate other studies related to multiple myeloma or Elotuzumab there are 807 and 738 trials respectively that are actively searching for participants."
Share this study with friends
Copy Link
Messenger